ROR gamma modulators (Pfizer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameROR gamma modulators (Pfizer)
Drug Alias NameROR gamma modulators (Karo Bio/Pfizer)ROR gamma modulators (Karo Bio)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma modulators
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKaro Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaro Pharma AbPfizer Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A